Le Lézard
Classified in: Science and technology
Subject: Event

Black Hat USA Announces Over 100 Briefings for its 27th Anniversary Event in Las Vegas


Black Hat, the cybersecurity industry's most established and in-depth security event series, today announced the release of its content lineup for Black Hat USA 2024. The live, in-person event will take place at the Mandalay Bay Convention Center in Las Vegas from August 3 to August 8.

On August 7 and August 8, attendees will gain insight into the latest in information security risks, developments, and trends. Briefings highlights include:

Two- and four-day Trainings will take place from August 3 to August 6 and feature a variety of in-person and virtual courses in artificial intelligence (AI), machine learning (ML), data science, cloud security, and more.

Trainings highlights include:

Business Hall passes, or Business passes, are currently available for the 2024 event. The Business Hall showcases the latest products and technologies from leading information security solution providers, and will take place from August 7 to August 8. Business passes provide access to the Keynotes, Arsenal, Sponsored Sessions, Bricks & Picks, and more. All Black Hat USA 2024 pass holders will have access to the Business Hall.

This year's Black Hat Arsenal at Black Hat USA will take place from August 7 to August 8. Black Hat Arsenal brings together researchers and the cybersecurity community to showcase and demonstrate their latest open-source tools and products in a conversational environment where presenters can interact with the attendees. This year's event will feature 90 in-person tool demos and six labs, spanning code assessment, exploitation and ethical hacking, network defense, open source intelligence (OSINT), and more.

Top Sponsors and Partners of Black Hat USA 2024 include:

For registration and additional information on Black Hat USA 2024, please visit www.blackhat.com/us-24.

About Black Hat

Black Hat is the cybersecurity industry's most established and in-depth security event series. Founded in 1997, these annual, multi-day events provide attendees with the latest in cybersecurity research, development, and trends. Driven by the needs of the community, Black Hat events showcase content directly from the community through Briefings presentations, Trainings courses, Summits, and more. As the event series where all career levels and academic disciplines convene to collaborate, network, and discuss the cybersecurity topics that matter most to them, attendees can find Black Hat events in the United States, Canada, Europe, Middle East and Africa, and Asia. For more information, please visit www.blackhat.com.


These press releases may also interest you

at 12:14
CapitaLand Investment Limited (CLI) has incorporated three new Scope 3 categories deemed material to its operations ? Purchased goods and operations, Fuel- and energy-related activities, and Upstream transportation and distribution ? and expanded the...

at 10:47
CapitaLand Investment Limited (CLI) has incorporated three new Scope 3 categories deemed material to its operations ? Purchased goods and operations, Fuel- and energy-related activities, and Upstream transportation and distribution ? and expanded the...

at 10:45
Sungrow, the global leading PV inverter and energy storage system provider, shared 10 major technological trends at the recent Ph.D Talk event in Shanghai. With an investment of 2.45 billion yuan (approximately 347 million) in R&D throughout 2023,...

at 10:36
On June 6, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), in collaboration with China Mobile, unveiled the world's first 800G hollow-core fibre transmission test network in Shenzhen-Dongguan, Guangdong. The development is a...

at 10:30
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equecabtagene Autoleucel (Eque-cel),...

at 10:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi® (glofitamab-gxbm) in combination with gemcitabine and...



News published on and distributed by: